Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BRISTOL MYERS SQUIBB

  • FDA Approval
  • March 07, 2024, 19:11 UTC
  • 32
  • 0 comments

FDA approve NIVOLUMAB;RELATLIMAB-RMBW

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • March 07, 2024, 18:47 UTC
  • 32
  • 0 comments

FDA approve EXENATIDE SYNTHETIC

Comment Full text

RUBICON

  • FDA Approval
  • March 07, 2024, 05:14 UTC
  • 36
  • 0 comments

FDA approve OXCARBAZEPINE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • March 06, 2024, 19:09 UTC
  • 34
  • 0 comments

FDA approve TOCILIZUMAB-AAAZG

Comment Full text

WYETH PHARMS INC

  • FDA Approval
  • March 06, 2024, 18:50 UTC
  • 40
  • 0 comments

FDA approve INOTUZUMAB OZOGAMICIN

Comment Full text

FORMOSA PHARMACEUTICALS INC

  • FDA Approval
  • March 06, 2024, 16:51 UTC
  • 35
  • 0 comments

FDA approve CLOBETASOL PROPIONATE

Comment Full text

HOSPIRA

  • FDA Approval
  • March 06, 2024, 10:03 UTC
  • 29
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • March 06, 2024, 10:03 UTC
  • 37
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • March 06, 2024, 10:03 UTC
  • 31
  • 0 comments

FDA approve PRAMIPEXOLE DIHYDROCHLORIDE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • March 06, 2024, 10:03 UTC
  • 31
  • 0 comments

FDA approve ACETYLCYSTEINE

Comment Full text
  • Previous
  • 534
  • 535
  • 536
  • 537
  • 538
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235879)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143296)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin